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Abstract
Background: Percutaneous drainage (PCD) and surgical intervention are two primary treatment options for
iliopsoas abscess (IPA). However, there is currently no consensus on when to use PCD or surgical intervention,
especially in patients with gas-forming IPA. This study compared the characteristics of patients with gas-forming
and non-gas forming IPA and their mortality rates under different treatment modalities. An algorithm for selecting
appropriate treatment for IPA patients is proposed based on our findings.
Methods: Eighty-eight IPA patients between July 2007 and February 2013 were enrolled in this retrospective study.
Patients < 18 years of age or with an incomplete course of treatment were excluded. Demographic information,
clinical characteristics, and outcomes of different treatment approaches were compared between gas-forming IPA
and non-gas forming IPA patients.
Results: Among the 88 enrolled patients, 27 (31%) had gas-forming IPA and 61 (69%) had non-gas forming IPA.
The overall intra-hospital mortality rate was 25%. The gas-forming IPA group had a higher intra-hospital mortality
rate (12/27, 44.0%) than the non-gas forming IPA group (10/61, 16.4%) (P < 0.001). Only 2 of the 13 patients in the
gas-forming IPA group initially accepting PCD had a good outcome (success rate = 15.4%). Three of the 11 IPA
patients with failed initial PCD expired, and 8 of the 11 patients with failed initial PCD accepted salvage operation, of
whom 5 survived. Seven of the 8 gas-forming IPA patients accepting primary surgical intervention survived (success
rate = 87.5%). Only 1 of the 6 gas-forming IPA patients who accepted antibiotics alone, without PCD or surgical
intervention, survived (success rate = 16.7%). In the non-gas forming IPA group, 23 of 61 patients initially accepted
PCD, which was successful in 17 patients (73.9%). The success rate of PCD was much higher in the non-gas forming
group than in the gas-forming group (P <0.01).
Conclusions: Based on the high failure rate of PCD and the high success rate of surgical intervention in our
samples, we recommend early surgical intervention with appropriate antibiotic treatment for the patients with
gas-forming IPA. Either PCD or primary surgical intervention is a suitable treatment for patients with non-gas
forming IPA.
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Background
Iliopsoas abscess (IPA), a suppurative collection within the
compartment of the psoas and iliacus muscles, was first
reported by Mynter et al. in 1881 [1]. It is an infrequent
but potentially life-threatening infectious disease. Prior to
introduction of effective anti-tuberculosis drugs, IPA
was once a common complication of tuberculous spinal
infection. With the common application of anti-tuberculosis
drugs, non-tuberculous pyogenic IPA has become the
predominant form. Clinically, IPA is classified according
to its origin [2]. Primary IPA is thought to be secondary
to an unrecognized staphylococcal bacteremia, while
secondary IPA is caused by underlying conditions such
as gastrointestinal or genitourinary tract diseases, spread
of infection from postoperative aortic aneurysm, spondy-
lodiskitis, osteomyelitis, septic arthritis, and infection
subsequent to renal surgery [1,3]. Primary IPA is often
seen in younger patients and in developing or tropical
countries, while secondary IPA occurs more frequently in
developed countries with mixed enteric flora [2]. In recent
decades, the incidence of primary IPA has gradually
increased as numbers of intravenous drug-abusers and
those afflicted with human immunodeficiency virus (HIV)
infection increase [1,4].
The psoas-muscle sign, the triad of fever, flank pain,
and limitation of hip movement, is noted in only 30%
patients [5]. Because of the rapid progress in advanced
imaging techniques, such as gallium-67 scanning, computed
tomography (CT), and magnetic resonance image (MRI)
in recent years, early diagnosis of IPA has become easier
despite initial clinical presentation that is frequently
ambiguous [6-8]. Although origin-based IPA classification
has been adopted in clinical practice, it does not help
clinicians make appropriate treatment decisions. Cur-
rently, whether percutaneous drainage (PCD) or surgical
intervention should be used in IPA patients remains
controversial because few studies with large sample sizes
have been performed. At present, PCD is considered
preferable to surgical intervention for the treatment of
IPA [9-11].
In this study, we compared demographic information,
laboratory data, microbiological distribution, origin of
infection, treatment modality (i.e., antibiotics alone, PCD,
and surgical intervention), and clinical outcomes between
patients with gas-forming IPA and non-gas forming
IPA. From these results, we established an evidence-
based algorithm for selecting an appropriate treatment
modality for IPA.
Methods
This retrospective study was approved by the institutional
review board of Taichung Veterans General Hospital (No.
CE13129). The data were retrieved from the electronic
clinical database of Taichung Veterans General Hospital, a
1,520-bed referral medical center in central Taiwan. The
diagnosis of IPA was confirmed by (1) documentation
of abscess within the iliopsoas muscle by either PCD or
surgery; or (2) classic CT or MRI finding of IPA with
compatible clinical presentation, laboratory data, and blood
cultures. Typical CT or MRI images in IPA patients
included the following features: (1) enlargement of
affected muscle, (2) rim enhancement of the abscess
wall with lower central attenuation, and (3) gas presence
either as an air–fluid interface or mottled air bubbles.
All CT and MRI images were reviewed by the primary
study investigators and one radiologist.
The primary outcome of this study was the intra-
hospital mortality of treated IPA patients. We defined
success of treatment as improvement in clinical condition,
decrement of IPA size in follow-up images, and discharge
alive after treatment with PCD, surgery, or antibiotics
alone. Failure of treatment was defined as mortality
during hospitalization or deterioration of a patient’s
clinical condition with accompanying non-decrement
of IPA size on follow-up images necessitating another
advanced treatment modality (i.e., antibiotics alone plus
PCD, antibiotics alone plus surgery, or PCD followed
by surgery). All the patients accepted a minimum
follow-up period of 2 months. Cases were excluded if
the patient was < 18 years old or had an incomplete
treatment course.
Eighty-eight IPA patients admitted to the hospital
between July 2007 and February 2013 were included in
this study. Demographic data, laboratory studies, etiological
pathogens, infection origins, management approaches,
clinical courses, and patient’s outcomes were coded for
further statistical analysis. Continuous variables were
reported as mean ± SD, whereas categorical variables were
described as the number and percentage of subjects.
Patients were divided into gas-forming IPA and non-gas
forming IPA groups. Further comparisons were performed
using Mann–Whitney U test for continuous variables
and chi-square test or Fisher’s exact test for categorical
variables. A P value of less than 0.05 was accepted as
statistically significant. Statistical analysis was performed
using the Statistical Package for the Social Sciences
Version 15.1 (SPSS Inc., Chicago, IL, USA).
Results
Clinical features and biochemistry
Of the 88 IPA patients enrolled (58 females, 30 males;
mean age 63.0 ± 15.6 years [range, 29–93 years]), 29
patients (33.0%) had bilateral IPA and 74 (84.1%) had
multiloculated IPA determined on CT. Mean maximal
transverse IPA cavity diameter on CT was 3.98 ± 2.31 cm.
Fever or hypothermia was noted in 74 patients (84.0%)
upon initial presentation to the hospital. IPA was of
primary origin in 21 patients (24%) and of secondary
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origin in 67 (76%). Severe sepsis was noted in 53 patients
(60.2%) upon initial presentation. The average length of
hospital stay was 36 ± 39 days (range, 2–328 days; median,
28 days) and the intra-hospital mortality rate was 25%.
Etiological pathogens
The microbiological documentation rate of all IPA pa-
tients via either pus or correlated blood cultures was
83.0% (73/88), including 59.3% (51/86) with positive blood
culture, and 75.7% (53/70) with positive pus culture.
Staphylococcus spp. were the most common pathogens
in this study, found in blood cultures in 27 patients and pus
cultures in 26; followed by Streptococcus spp.; Klebsiella
pneumoniae; and Escherichia coli. Methicillin-resistant
Staphylococcus aureus (MRSA) was found in blood cultures
in 10 patients and pus cultures in 9 patients. Anaerobic
blood cultures were positive in 7 patients and anaerobic
pus cultures were positive in 13 patients. Only one pus
culture was positive for tuberculosis.
Origins of secondary IPA
Among the 61 secondary IPA patients, the most common
etiologies were skeletal (37 patients, 60.7%), followed
by cardiovascular (11 patients, 18.0%) and urinary tract
(10 patients, 16.4%) (Table 1). Cardiovascular origins of
IPA included 3 cases (4.9%) of infective endocarditis with
distal septic infection, 4 cases (6.6%) of abdominal aortic
aneurysm with subsequent infection after endovascular
stent implantation, and 2 cases (3.3%) of infected aortic
aneurysm.
Imaging studies
CT confirmed the diagnosis of IPA in all patients. MRI
was performed in 20 patients with poor treatment response
or high suspicion for infection of adjacent structures.
Accordingly, osteomyelitis/spondylodiskitis and epidural
abscess were demonstrated in 18 (20.5%) and 11 (12.5%)
patients, respectively. The 11 patients with epidural
abscess underwent subsequent surgical intervention
and 3 expired.
Causes of mortality
The ultimate causes of mortality of our patients were
examined by two research physicians via review of medical
records. In controversial cases, the primary care physicians
were consulted and consensus was reached after thorough
discussion. There were 22 mortality cases in our study
group, and 16 cases (72.7%) expired due to refractory
sepsis. Six cases (27.3%) expired because of comorbidities,
including 2 from massive upper gastrointestinal bleeding
and 2 from hemorrhagic shock caused by aortic aneurysm
rupture. The causes of mortality of the remaining 2 cases
were unexpected cardiac arrest and end-stage cancer.
Initial treatment options
Once the patients with suspicious infection presented
to the hospital, empirical antibiotics were prescribed
within 2 hours. Third-generation cephalosporin plus
metronidazole (15/88, 17.0%) or carbapenem (13/88, 14.8%)
were most often prescribed initially to our study cases.
Antibiotics were adjusted after demonstration of IPA via
advanced image studies or available blood/pus cultures.
PCD and surgery were the standard treatment modalities
for IPA if drainage was indicated. Patients who did not
require (because the condition was mild) or were not
candidates for (because the condition was too severe for
invasive treatment) PCD or surgery received therapy with
antibiotics alone.
Table 1 Classification of IPA origin between gas-forming
IPA and non-gas forming IPA patients
Gas-forming
IPA (n = 27)
Non-gas forming
IPA (n = 61 )
Origin (Primary:Secondary) 3:24 18:43




Ilio-sacral joint septic arthritis 0 7
Hip septic arthritis 1 2
Intra-abdominal 1 (3.7%) 4 (6.6%)
Necrotizing pancreatitis 0 2
Appendicitis 0 1
Colon cancer with abscess 1 0
Post GI procedure 0 1a
Cardiovascular 6 (22.2%) 5 (8.2%)
Abdominal aortic aneurysm post-
stent implantation
2 2
Infected aortic aneurysm 2 0
Infective endocarditis 0 3
Catheter related 2 0
Urinary tract 5 (18.5%) 5 (8.2%)
Acute pyelonephritis 2b 2c
Post GU procedure 3d 2e
Prostate abscess 0 1




Limb necrotizing fasciitis 1 (3.7%) 0
aPost appendectomy and colocutaneous fistula repair.
bIncluding 2 EPN.
c Including 1 EPN.
dIncluding 1 post nephrectomy, 1 post Bench surgery, and 1 renal stone
post ESWL.
eIncluding 2 post nephrectomy.
fEndometrioid cancer post operation.
EPN, emphysematous pyelonephritis; ESWL, extracorporeal shock wave
lithotripsy; GI, gastrointestinal; GU, genitourinary.
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A comparison of characteristics of IPA patients between
different initial treatment modalities (antibiotics alone,
PCD, or surgery) is shown in Table 2. Patients who under-
went antibiotic therapy alone were older (P = 0.005) and
had smaller mean diameter of the IPA cavity (P < 0.0001)
and lower platelet count (P = 0.016) than patients receiv-
ing other forms of treatment. Impaired renal function
was more frequent in this group (P < 0.05). Shorter length of
hospital stay (P = 0.001) and higher mortality rate (P=
0.002) were also observed. Other variables were not different
between the three groups. Initial treatment with antibiotics
alone was chosen in our study group when the IPA was too
small to be drained by PCD (n = 9) or when patients were
too weak to undergo an invasive procedure (n = 15).
Factors contributing to mortality
Possible contributions of age, sex, clinical and laboratory
variables to mortality were analyzed using univariate
analysis (Table 3). Results revealed that age, gas-forming
IPA, white blood cell (WBC) count, platelet count, blood
urea nitrogen (BUN), creatinine, potassium, and secondary
IPA origin were significantly associated with mortality.
Further Cox regression analysis of these variables as
well as bilateral IPA revealed that none was associated
with mortality rate except initial treatment. The hazard
ratio (HR) for treatment using antibiotics alone was
5.34 (95% confidence interval [CI], 1.27–22.56), whereas
surgery had no effect on mortality rate (HR = 0.28, 95% CI
0.04–2.02, P = 0.207).
Table 2 Comparison of patient characteristics between initial treatment with antibiotics alone, PCD, or surgery
Antibiotics (n = 24) PCD (n = 36) Surgery (n = 28) P value
Mean±SD Mean±SD Mean±SD
Age (years) 72.0±13.8 59.6±15.6 60.0±14.6 0.005*
Sex (F:M) 15:9 23:13 20:8 0.752
Gas-forming IPA 18 (75.0%) 23 (63.9%) 20 (71.4%) 0.631
Bilateral 10 (41.7%) 10 (27.8%) 9 (32.1%) 0.530
Multiloculated IPA collection pattern 17 (70.8%) 33 (91.7%) 24(85.7%) 0.093
Mean maximal transverse IPA cavity diameter on CT (cm) 2.2 ±1.5 5.2 ±2.1 4.0±2.2 <0.0001*
DM 10 (41.7%) 13 (36.1%) 11 (39.3%) 0.907
Hypertension 8 (33.3%) 12 (33.3%) 13 (46.4%) 0.497
CKD 9 (37.5%) 7 (19.4%) 3 (10.7%) 0.060
Malignancy 4 (16.7%) 9 (25.0%) 4 (14.3%) 0.520
Liver cirrhosis 4 (16.7%) 6 (16.7%) 2 (7.1%) 0.479
Fever or hypothermia 20 (83.3%) 31 (86.1%) 23 (82.1%) 0.905
Severe sepsis 18 (75.0%) 29 (80.6%) 21 (75.0%) 0.830
WBC (/μL) 18900±9428 17672 ±9018 15354±7426 0.344
Bandemia (No. of patients) 12 (50.0%) 17 (47.2%) 9 (32.1%) 0.353
Hb (g/dL) 10.8±2.4 10.7 ±2.3 10.7±2.7 0.996
Platelet (×103/μL) 185.5±140.9 309.2 ±179.0 255.6±144.8 0.016*
BUN (mg/dL) 65.6±67.1 36.8 ±37.1 32.4±28.0 0.041*
Creatinine (mg/dL) 3.5±4.0 2.2 ±2.0 1.43±0.9 0.037*
ALT (U/L) (n = 24 vs 35 vs 28) 106.3±250.6 51.0 ±77.7 80.1±244.9 0.768
Na (mEq/L) 132.3±8.5 133.4 ±5.6 135.0±5.5 0.258
K (mEq/L) 4.4±1.0 4.0 ±0.5 4.1±0.7 0.223
CRP (mg/L) 16.0±10.5 21.9 ±10.1 19.3±12.2 0.083
CK (U/L) (n = 22 vs 29 vs 25) 539.3±1711.5 175.6 ±302.3 183.1±535.1 0.309
Initial blood glucose (mg/dL) (n = 24 vs 34 vs 28) 180.0±116.0 208.0 ±151.3 155.3±88.6 0.369
Primary:Secondary origin 8:16 8:28 5:23 0.408
Mortality 12 (50.0%) 8 (22.2%) 2 (7.1%) 0.002*
Length of hospital stay (days) 19.4±15.2 44.9 ±55.3 38.8±19.5 0.001*
*P < 0.05.
ALT, alanine aminotransferase; BUN, blood urea nitrogen; CK, creatine kinase; CKD, chronic kidney disease; CRP, C-reactive protein; CT, computed tomography; DM,
diabetes mellitus; Hb, hemoglobin; IPA, iliopsoas abscess; K, potassium; Na, sodium; PCD, percutaneous drainage; SD, standard deviation; WBC, white blood cells.
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Comparison between patients with gas-forming and
non-gas forming IPA
Results of comparisons between gas-forming IPA and
non-gas forming IPA patients are summarized in Table 4.
Among the 88 patients enrolled, 27 (30.7%) had gas-
forming IPA and 61 (69.3%) had non-gas forming IPA.
No sex predominance between groups was identified.
Patients in the gas-forming IPA group showed a higher
incidence of bilateral involvement (14/27, 51.9%) than
the non-gas forming IPA group (15/61, 24.6%) (P < 0.05).
Neither the incidence of multiloculated IPA collection
pattern (92.5% versus 80.3%) nor the mean maximal
transverse IPA cavity diameter (4.21 cm versus 3.87 cm)
was significantly different between the 2 groups. The
gas-forming IPA group had a higher intra-hospital mor-
tality rate (12/27, 44.0%) than the non-gas forming IPA
group (10/61, 16.4%) (P < 0.001). No difference in under-
lying disease, primary versus secondary origin, biochemistry
profile, or average length of hospital stay was found
between the 2 groups.
The overall microbiological documentation rate was
85.2% (23/27) in patients with gas-forming IPA and
Table 3 Univariate and multivariate analyses of effects of age, sex and clinical variables on mortality rate
Univariate analysis Multivariate analysisa
HR 95% CI P value HR 95% CI P value
Age (years) 1.05 (1.010-1.083) 0.013* 1.03 (0.986-1.071) 0.204
Sex-female 1.06 (0.421-2.655) 0.905 1.21 (0.369-3.997) 0.749
Gas-forming IPA 2.57 (1.060-6.250) 0.037* 1.93 (0.425-8.804) 0.393
Bilateral IPA 2.28 (0.943-5.524) 0.067 1.76 (0.563-5.481) 0.332
Multiloculated IPA collection pattern 0.85 (0.248-2.938) 0.801
Mean maximal transverse IPA cavity diameter on CT (cm) 0.93 (0.747-1.162) 0.533
DM 1.21 (0.490-2.996) 0.679
Hypertension 0.41 (0.145-1.134) 0.085
CKD 1.22 (0.459-3.265) 0.687
Malignancy 1.34 (0.442-4.057) 0.605
Liver cirrhosis 1.19 (0.346-4.080) 0.785
Fever or hypothermia 1.53 (0.351-6.647) 0.572
Severe sepsis 29.17 (0.215-3952) 0.178
WBC (/μL) 1.00 (1.000-1.000) 0.004* 1.00 (1.000-1.000) 0.109
Bandemia 1.76 (0.722-4.315) 0.213
Hb (g/dL) 0.89 (0.737-1.084) 0.255
Platelet (×103/μL) 1.00 (0.992-0.999) 0.013* 1.00 (0.992-1.001) 0.109
BUN (mg/dL) 1.01 (1.005-1.017) 0.001* 1.00 (0.983-1.010) 0.623
Creatinine (mg/dL) 1.12 (1.009-1.233) 0.033* 0.93 (0.738-1.178) 0.555
ALT (U/L) 1.00 (0.998-1.002) 0.702
Na (mEq/L) 1.01 (0.946-1.083) 0.721
K (mEq/L) 2.54 (1.442-4.485) 0.001* 1.36 (0.674-2.761) 0.389
CRP (mg/L) 0.98 (0.935-1.021) 0.303
CK (U/L) 1.00 (0.999-1.001) 0.972
Initial blood glucose (mg/dL) 1.00 (0.996-1.003) 0.750
Secondary IPA origin 0.37 (0.149-0.931) 0.035* 0.35 (0.081-1.490) 0.154
Initial treatment
Antibiotics alone 6.49 (2.132-19.753) 0.001* 5.34 (1.266-22.558) 0.023*
PCD Reference Reference
Surgery 0.51 (0.098-2.627) 0.418 0.28 (0.039-2.017) 0.207
aadjusted for age, gender, gas-forming IPA, bilateral IPA, WBC, Platelet, BUN, creatinine, K, secondary IPA origin, and initial treatment.
*P < 0.05.
ALT, alanine aminotransferase; BUN, blood urea nitrogen; CK, creatine kinase; CKD, chronic kidney disease; CRP, C-reactive protein; CT, computed tomography; DM,
diabetes mellitus; Hb, hemoglobin; HR, hazard ratio; IPA, iliopsoas abscess; K, potassium; Na, sodium; PCD, percutaneous drainage; SD, standard deviation; WBC,
white blood cells.
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82.0% (50/61) in patients with non-gas-forming IPA.
The distribution of pathogens in blood and pus cultures
is summarized in Table 5. The predominant etiological
micro-organisms in the non-gas forming IPA group were
gram-positive cocci (GPC); mainly Staphylococcus spp.
The incidences of GPC and gram-negative bacilli (GNB)
were equal in the gas-forming IPA group. The incidence
of GNB in blood or pus cultures was higher in the
gas-forming IPA group than in the non-gas forming
IPA group (51.9% versus 27.9%) (P < 0.05). The same
trend was found for the anaerobes (37.0% versus 14.8%)
(P < 0.05).
All patients in this study were initially treated with
empirical antibiotics. Only 2 among the 13 gas-forming
IPA patients initially undergoing PCD had a successful
outcome (success rate = 15.4%); 3 of the 11 IPA patients
with failed initial PCD expired; and 8 of the 11 patients
with failed initial PCD underwent salvage operation, of
whom 5 survived. Seven of the 8 gas-forming IPA patients
who underwent primary surgical intervention survived
(success rate = 87.5%). Six gas-forming IPA patients were
treated with antibiotics alone without PCD or surgical
intervention, only 1 of whom survived (success rate =
16.7%). In the non-gas forming IPA group, 23 of 61
patients initially underwent PCD; success was achieved
in 17 patients (success rate = 73.9%). The success rate
of PCD was higher in the non-gas forming than in the
gas-forming IPA group (P <0.01) (Table 6). Nineteen of
20 non-gas forming IPA patients undergoing primary
operation survived. The survival rates of patients who
received antibiotics alone in the gas-forming IPA and
non-gas forming IPA groups were 16.7% (1/6) and
61.1% (11/18), respectively. The treatment approaches
in the gas-forming IPA and non-gas forming IPA
groups are delineated in Figure 1. We also conducted
a Kaplan-Meier analysis to compare the survival rate
within 60 days between the 2 groups. Log rank test
showed a higher survival rate in the non-gas forming
IPA group (77.9%) than in the gas-forming group
(51.7%) (P < 0.05) (Figure 2).
Discussion
Iliopsoas muscles are susceptible to infections from
distant sites and contiguous structures because of their
rich blood supply and overlying retroperitoneal lymph-
atic systems. IPA is often overlooked because of its
insidious onset, and subsequent severe sepsis may be
life-threatening. Although the exact incidence of IPA is
unknown, more and more cases are being identified
because of widespread application of CT in suspected IPA
patients. Despite recent advances in diagnostic modalities,
the mortality rate of IPA has not improved much (6.7% in
a study by Ricci in 1986 and 5% in a study by Navarro
in 2009) [2,12]. In our study, the mortality rate in IPA
patients (22/88, 25%) was higher than that reported in
a meta-analysis conducted by Lai et al. (8%, 55/682,
between 1986 and 2011) [9]. However, because those
patients were from various medical settings in different
countries, the results of that meta-analysis cannot be
used as the gold standard for clinical comparison, and
Table 4 Comparison between gas-forming IPA and






(n = 27) (n = 61 )
Mean±SD Mean±SD
Age (years) 67.8±13.9 61.1±16.0 0.053
Sex (F:M) 14:13 44:17 0.064




Mean maximal transverse IPA
cavity diameter on CT (cm)
4.21±1.79 3.87±2.51 0.166
DM 13(48.2%) 21(34.4%) 0.223
Hypertension 8(29.6%) 25(41.7%) 0.284
Uremiaf 3(11.1%) 8(13.1%) 1.000
CKD 5(18.5%) 14(23.0%) 0.641
Malignancy 4(14.8%) 13(21.7%) 0.456
Liver cirrhosisf 1(3.7%) 11(18.0%) 0.096





Severe sepsis 27(100.0%) 26(67.2%) 0.002*
WBC (/μL) 20363±11077 15900±7059 0.132
Bandemia (No. of patients) 15(55.6%) 23(37.7%) 0.119
Hb (g/dL) 10±2.4 11±2.4 0.056
Platelet (×103/μL) 244.7±205.2 264.5±145.0 0.234
BUN (mg/dL) 55.4±55.0 37.9±41.9 0.053
Creatinine (mg/dL) 2.5±2.1 2.2±2.8 0.158
ALT (U/L) (n = 27 vs 60) 68.5±110.4 78.8±225.3 0.287
Na (mEq/L) 132.3±6.5 134.2±6.5 0.132
K (mEq/L) 4.3±0.8 4.1±0.7 0.178
CRP (mg/L) 217.8±92.8 184.8±116.9 0.168
CK (U/L) (n = 22 vs 54) 207.4±360.3 314.3±1150.0 0.439
Initial blood glucose
(mg/dL) (n = 27 vs 59)
211.4±139.9 170.0±115.9 0.098
Primary:Secondary origin 3:24 18:43 0.062
Mortality 12(44.4%) 10(16.4%) 0.005*
Length of hospital stay (days) 37.6±32.8 35.3±41.6 0.906
fFisher’s Exact Test. *P < 0.05.
ALT, alanine aminotransferase; BUN, blood urea nitrogen; CK, creatine kinase;
CKD, chronic kidney disease; CRP, C-reactive protein; CT, computed tomography;
DM, diabetes mellitus; Hb, hemoglobin; IPA, iliopsoas abscess; K, potassium; Na,
sodium; SD, standard deviation; WBC, white blood cells.
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further clarification is needed. Among the 88 patients in
our study group, 24 (27.3%) had already been hospitalized
in other hospitals and were referred to us because of poor
treatment response. The mortality rate among these
patients was high (7/24, 29.2%). The remaining patients
(64/88, 72.7%) were admitted via our emergency depart-
ment (ED) with initial severe illness. In addition, severe
sepsis was frequently observed in our total study group.
The general poor health of the patients was probably
the major cause of high mortality in the study group. In
addition, at our hospital, more conservative treatment
policies were adopted because of patients’ older age, which
itself might have contributed to a higher mortality rate.
Other possible explanations of the high mortality rate
include large number of gas-forming IPA cases and
predominance of secondary IPA.
The presentations of IPA in our study varied, including
fever, flank pain or back pain, abdominal pain, thigh
lumps, altered consciousness, and even shock. The initial
nonspecific symptoms; e.g., nausea, general weakness,
intermittent mild fever, or low back soreness, might
easily be ignored by patients. We attempted to evaluate
how long the patients had been ill via a complete medical
record review. Pre-presentation symptoms could not be
evaluated definitively in 24 of 88 patients (27.3%) who
had stayed in other hospitals for periods of time. A
higher mortality rate (7/24, 29.2%) was noted in this
group. Additionally, the morphology of IPA pattern,
according to the images in our hospital, might have
been influenced by prior therapy. Sixty-four patients
(72.7%) in our study were directly referred from another
ED because of severe illness or initially sought medical
Table 5 Distribution of pathogens between gas-forming IPA and non-gas forming IPA patients
Gas-forming n = 27 Non-gas forming n = 61
Blood Pus Blood Pus
GPC 10 (37.0%) 12 (44.4%) 30 (49.2%) 28 (45.9%)
Staphylococcus spp. 6 6 21 20
MRSA 3 2 7 7
OSSA 3 3 11 11
Coagulase-negative Staphylococcus 0 1 3 2
Streptococcus spp. 4 4 8 6
Enterococcus 0 2 1 2
GNB 9 (33.3%) 14 (51.9%) 6 (9.8%) 13 (21.3%)
Escherichia coli 1 5 1 4
Klebsiella pneumoniae 3 4 0 6
Others
Anaerobics 3 (11.1%) 9 (33.3%) 4 (6.6%) 6 (9.8%)
Fungus 0 1 (3.7%) 2 (3.3%) 3 (4.9%)
TB 0 0 0 1 (1.6%)
Mixed flora 3 (11.1%) 7 (25.9%) 8 (13.1%) 11 (18.0%)
MDR isolates 2 (7.4%) 3 (11.1%) 0 3 (4.9%)
GNB, Gram-negative bacilli; GPC, Gram-positive cocci; IPA, iliopsoas abscess; MDR, multiple-drug resistant; MRSA, methicillin-resistant Staphylococcus aureus; OSSA,
oxacillin-sensitive Staphylococcus aureus.
Table 6 Success rate of different management pathways between gas-forming IPA and non-gas forming IPA patients
Gas-forming IPA Non-gas forming IPA P value
(n = 27) (n = 61 )
Total number of initial treatments with PCD 13 (48.2%) 23 (37.7%) 0.358
PCD success rate 2/13 (15.4%) 17/23 (73.9%) 0.0007**
Total number undergoing surgical debridement 16 (59.3%) 25 (41.0%) 0.113
Primary operation success ratef 7/8 (87.5%) 19/20 (95.0%) 0.497
Salvage operation success rate (in patients with failed PCD)f 5/8 (62.5%) 4/5 (80.0%) 1.000
Antibiotics alone success ratef 1/6 (16.7%) 11/18 (61.1%) 0.155
fFisher’s Exact Test. **P < 0.001.
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assistance in our hospital. The majority of patients in
this group (55/64, 85.9%) had a long illness prior to
presentation; 12.55 days on average. Among these 55
patients, 17 (30.9%) had bilateral IPA and 49 (89.1%)
had multiloculated IPA. The remaining 9 patients (9/
64, 14.1%) in this group could not be evaluated because
medical records were unclear or because patients had
deterioration of consciousness upon initial presentation
and ultimately expired. In brief, the late presentation of
most of our patients may have contributed to the high
total mortality.
IPA is clinically classified into primary and secondary
origins according to its initial infection site. In 1986,
Ricci et al. described 286 cases of primary IPA, mainly
young patients from developing countries [2]. There were
90 cases of secondary IPA, which were almost exclusively
from developed countries, and the most common etiolo-
gies were Crohn’s disease, followed by appendicitis and
colon inflammation or cancer. Since then, more and more
patients have been found to have secondary rather than
primary IPA. In 2009, Navarro et al. reported 124 cases in
a multi-center study, 78.2% with secondary IPA, and a
single-center study by Carolyn et al. in 2001 demonstrated
80% of 61 cases having secondary IPA. The main sources
of secondary IPA in the study by Navarro et al. were
skeletal (50.5%), followed by gastrointestinal tract (24%)
and genitourinary tract (17.5%). Our study revealed a
similar trend with predominance of secondary IPA
(76.1%) in which the most common infection origins
were skeletal, followed by cardiovascular system and
urinary tract. The higher prevalence of secondary IPA
reported recently and in our study may be attributable
to the widespread application of CT and MRI [13].
These imaging modalities can clearly delineate adjacent
structures, especially the vertebrae and epidural space,
and it is therefore likely that the infectious focus will
be clarified. Furthermore, in our report, 11 patients of
secondary IPA originated from cardiovascular system,
including abdominal aortic aneurysm (AAA) post-stent
implantation with subsequent infection, infected aortic
aneurysm, and infective endocarditis, all of which have
rarely been mentioned in the literature [14,15].
Gas-formation is an important predictor of clinical out-
come for patients with liver abscess and acute pyelo-
nephritis [16,17]. Furthermore, in patients with acute
pyelonephritis, the treatment policy depends mainly on
whether the gas-forming (emphysematous) change is de-
tected within the urinary tract. The major components of
the gas in emphysematous pyelonephritis are nitrogen,
hydrogen, carbon dioxide, and oxygen, and mixed acid
fermentation has been proposed as the major mechanism
of gas production because of the hydrogen content
[17,18]. Other authors have indicated that rapid tissue
catabolism complicated by impaired transport of end
products around the infection site produces the gas
[19]. Based on the clinical consensus that in acute
pyelonephritis gas formation is the major criterion for
further treatment decisions, we propose a new algorithm
for determining treatment modality in IPA patients
according to the presence of gas. In our study, GNB
and anaerobic infections were more often discovered
in patients with gas-forming IPA than in those with
non-gas forming IPA. This phenomenon may explain
the mechanism of gas formation and the development
of a fulminant course of IPA.
Abscess drainage plus antibiotic treatment is essential
for appropriate management of IPA patients. Options
for drainage are surgery or PCD. Generally, IPA patients
with concurrent intra-abdominal or retroperitoneal abnor-
malities such as ruptured appendicitis or ruptured infected
aortic aneurysm require surgery to clean out or repair
the infected foci. Surgical intervention may provide more
effective drainage than PCD, especially in patients with
multiloculated IPA [4]. IPA patients were often treated
Figure 1 Management of patients with gas-forming (A) and non-gas forming (B) IPA. IPA, iliopsoas abscess.
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Figure 2 Kaplan-Meier analysis of cumulative survival rate during a 60-day hospital stay between patients with gas-forming and
non-gas forming IPA. IPA, iliopsoas abscess.
Figure 3 Suggested clinical management algorithm for IPA patients. IPA, iliopsoas abscess.
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with surgical debridement in the 1980s, when imaging
techniques were still uncommon [2]. Afaq et al. also
reported no mortality in 72 cases in Nepal in which all
of the patients received surgical intervention as the first
choice of treatment [20]. Recent studies have suggested
that IPA can be successfully treated with antibiotics
plus PCD [11,21], but not all of the cases in our study
could be cured by PCD, especially when the IPA was
gas-forming. If there are strong indications for primary
operation, such as ruptured infected aortic aneurysm,
ruptured appendicitis, or epidural abscess with spinal cord
compression, surgical intervention should not be delayed.
Furthermore, in our study, surgical intervention was
preferred when gas-forming IPA was observed because
of the higher failure rate of PCD. However, PCD plus
appropriate antibiotics is adequate for treating patients
with non-gas forming and solitary IPA. In addition,
PCD remains an option for IPA patients who are not
suitable for operation under general anesthesia. The
suggested treatment algorithm based on the results of
our study is delineated in Figure 3.
The major strength of this study is the use of a large
number of IPA patients from a single center. Although
previous multi-center study used larger sample sizes,
many relevant variables could not be evaluated because
of differences in record format across medical centers.
However, there are several limitations to this study. First,
there is no international consensus for IPA treatment;
treatment policy depends on the treating physicians, whose
training and clinical experience may play roles. Second,
no matter which modality of treatment is chosen, the
origin of infection may affect the clinical outcome, and
this could not be evaluated in this study. Third, recurrence
was not evaluated in this study. Thus, it is unknown
whether repeated PCD or surgical intervention was
performed. Fourth, the complexity of the disease varied
in our sample.
Conclusions
Our findings suggest that classification of IPA patients
into gas-forming IPA or non-gas forming IPA groups
may help physicians make early and definitive decisions
with regard to treatment choices. Our study showed that
PCD treatment for patients with gas-forming IPA resulted
in a high failure rate and increased intra-hospital mortality
rate. We recommend early surgical intervention with
appropriate antibiotic treatment for gas-forming IPA
patients. PCD is adequate for the management of patients
with solitary and non-gas forming IPA, especially for
primary IPA.
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